Lipitor 20mg Pfizer Treatment for total cholesterol (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Atorvastatin

Ingredient

Composition informationContent
Atorvastatin20mg

Uses

Indications

Atorvastatin is appointed to support the diet in the treatment of patients with hypercholesteroline blood cholesterol predators (hyperlested blood cholesterol is heterozygous and non -family), hyperlipidemia (mixed) (LLA and LLB groups according to Fr and Frederson), increased truglycer. Blood (Group IV, according to the classification of Fredrickson) and in patients with blood betalipoprotein disorders (group III according to Fredrickson classification) without adequate response to the diet.

To reduce total cholesterol (C - total), low density lipoprotein cholesterol (LDL - C), apolipoprotein B (APO B) and triglyceride (TG) and help increase high density cholesterol lipoprotein (HDL - C).

Atorvastatin is also indicated to reduce C - Total and LDL - C in patients with hypercholesterolemia hyperlested family.

Lipitor 20mg is indicated in the following cases:

Provisions of cardiovascular complications

For patients without manifestations of cardiovascular disease (CVD) clinically, and patients with or without blood lipid disorders, but there are risk factors for coronary heart disease (CHD) such as smoking, high blood pressure, diabetes, HDL - C low, or patients with family history patients with early coronary coronary artery disease, Avortasatin is designated to:

  • Reduce the risk of death from coronary artery disease and myocardial infarction (Mi).
  • Reduce the risk of myocardial infarction.

    In children (10 - 17 years old)

    Atorvastatin is assigned to support diets to reduce total cholesterol, LDL - C, and APO B in boys and girls who have menstruation from 10 to 17 years old with hyperlested hyperlemom cholesterol and after treatment with appropriate diets, patients still have the following characteristics:

  • LDL - C still> 190mg/dl or LDL - C level> 160mg/dl. Is a reducing enzyme inhibitor 3 - hydroxy - 3 - methylglutaryl - Coenzyme A (HMG - CoA). This enzyme catalyzes HMG - COA transformation into Mevalonate, which is an early stage and limits the speed of cholesterol biosynthesis. In patients with high cholesterol or zygote genetic cholesterol or heterozygous, non -genetic blood cholesterol and mixed blood lipid disorders, Atorvastatin reduces total cholesterol, lipoprotein cholesterol low molecular weight (LDL - C) and Apolipoprotein B (APO B). Atorvastatin also reduces lipoprotein cholesterol lipoprotein with very low molecular weight (VLDL - C) and triglycerides (TG) and increases the lipoprotein cholesterol lipoprotein with high molecular weight (HDL - C).

    pharmacokinetics

    Absorption

    Atorvastatin absorbs quickly after drinking, reaching the peak concentration (CMAX) in plasma within 1 to 2 hours. After oral, Atorvastatin is about 95 - 99% of the film -based film bags of oral solution.

    Distribution

    The average distribution of Atorvastatin is approximately 381L. Atorvastatin binds plasma protein above 98%. Atorvastatin body oil should pass through the bloody barrier.

    Metabolism

    Atorvastatin is metabolized by Cytocrom P450 3A4 (O - and P - Hydroxylation and many different oxidant beta products). About 70% of HMG inhibitors - COA Reductase during circulation is due to active trips.

    Elimination

    Atorvastatin is mainly eliminated through bile after metabolism by the liver or outside the liver. The average selling time in the plasma of Atorvastatin is about 14 hours. Half of the activity of HMG - Coa Reductase inhibitors is about 20 to 30 hours due to the contribution of active metabolites.

  • Before taking Lipitor 20mg Pfizer Treatment for total cholesterol (3 blisters x 10 tablets)

    How to use

    Take oral once a day at any time, with or not accompanied by food.

    Dosage

    Dosage is between 10mg to 80mg once a day. The starting and maintenance dose should be concretized for each patient depending on the initial LDL - C level, the goals of treatment, and the patient's response.

    Increasing primary blood cholesterol and hyperlipidemia

    Most patients are controlled with atorvastatin dose 10mg x 1 time/day.

    Hyper cholesterol is homozygous

    Currently there is only limited data.

    Atorvastatin dose in patients with hypercholesteroline hypercholesteroline hypertension is 10mg to 80mg/day, in these patients, Atorvastatin should be used as a supportive medicine for other lipid treatments (eg LDL separation) or if these methods are not available.

    Cardiovascular Prevention

    Dose in initial backup tests is 10mg/day. Higher doses may be taken to achieve concentration (LDL -) cholesterol according to current instructions.

    Patients with renal failure

    No need to adjust the dose in patients kidney failure (see the cautious part when using the drug).

    Patients with liver failure

    Should be carefully used lipitor in patients with liver failure. Contraindicated lipitor in patients with progressive liver disease (see the contraindications).

    Elderly patients

    Safety and effectiveness of drugs in patients over 70 years of age using recommended dose is similar to the common population group.

    Children

    Hyper cholesterol.

    For patients with hypercholesteroline hypercholesterol, heterozygous family aged 20 years and older, Atorvastatin's recommended starting dose is 10mg daily, can increase daily dose up to 80mg according to the response and tolerance capacity.

    What to do when overdose? In case of overdose, patients need to be treated with symptoms and use necessary support measures. Checking liver function should be performed and serum CK levels need to be controlled. Because most Atorvastatin is attached to plasma proteins, dialysis almost does not increase the excretion of avortastatin from the body.

    What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

    Side Effects

    When using lipitor, you may experience unwanted effects (ADR).

    Common, ADR> 1/100

  • Infections and parasites: Rhinitis throat.
  • immune: allergic reactions.
  • Metabolism and nutrition: Hypergaric hyperglycemia.
  • nerve: headache.
  • Respiratory, chest and mediastinum: Archical angina, nosebleeds.
  • digestive: constipation, flatulence, indigestion, nausea, diarrhea.
  • muscle - bone and connective tissue: muscle pain, joint pain, headache, muscle spasm, joint swelling, back pain.
  • Testing: Abnormal liver function test, increased blood creatin.

    Uncommon, 1/1000

  • Metabolism and nutrition: lower blood glucose, weight gain, anorexia.
  • Mental: nightmares, insomnia. nerve: dizziness, paresthesia, reducing sensation, taste disorder, insomnia.

  • eyes: blurred vision.
  • ears and inner ears: tinnitus.
  • digestive: vomiting, abdominal pain upper and lower, belching, pancreatitis. liver - bile: hepatitis.

    Skin and subcutaneous tissue: urticaria, skin rash, itching, hair loss .

  • muscle - bone and connective tissue: Pain, muscle fatigue.
  • Systemic and condition where the drug is used: Difficult, weakness, chest pain, peripheral edema, exhaustion, fever.
  • Testing: positive leukemia.
  • Rare, 1/10000

  • Blood and lymphatic system: thrombocytopenia.
  • Neurological: peripheral neuropathy.
  • Eye: visual disorders. liver - bile: cholestasis.

    Skin and subcutaneous tissue: Neuritis, puffer dermatitis include diverse roses, Stevens - Johnson syndrome and poisoned donation.

  • muscle - bone and connective tissue: muscle disease, muscle inflammation, muscle pattern, tendon trauma, sometimes complications due to blood vessels.
  • Very rare, ADR

  • Immune: Hypersensitivity.
  • ears and inner ears: hearing loss.
  • liver: liver failure.
  • Reproduction and mammary gland: female mammary glands.
  • Unknown frequency

  • Muscle - Bone and connective tissue: Mechanical necrosis through immunity.
  • Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    Contraindicated

    Lipitor contraindicated in the following cases:

    Hypersensitivity to any ingredients of the drug.

    Having progressive liver disease or increased serum transaminase is not explained in excess of the upper limits of normal levels.

    During pregnancy, breastfeeding and in women is likely to not use appropriate contraception.

    Precautions for use

    Effects on the liver

    should conduct liver function tests before the beginning of treatment and periodically later. Patients should be tested for liver function when there are any signs or symptoms that suggest liver damage. If transaminase increased 3 times higher than the normal limit (ULN), the dose should be reduced or discontinued with Atorvastatin. Be cautious when using Atorvastatin in patients drinking a lot of alcohol or a history of liver disease.

    Hemorrhagic stroke

    In a post -testing analysis on mutant groups in patients without coronary artery disease (CHD) with stroke or recent brain anemia (TIC), the risk of stroke due to hemorrhage in patients starting treatment with Atorvastatin 80mg is higher than placebo. The risk increases more in patients who have had previous hemorrhagic stroke or hole infarction.

    For patients who have had previous hemorrhagic strokes or blood loss, the balance between the risk and the benefits of Atorvastatin 80mg is not sure and should carefully consider the risk of hemorrhagic stroke before the beginning of treatment.

    Mechanical effects - Bone

    As other HMG - Coa Reductase inhibitors, Atorvastatin can sometimes affect skeletal muscles and cause muscle pain, muscle inflammation and muscle disease, which can progress to muscle and muscle, a condition that can be fatal, characterized by a significant increase in creatin kinase (CK) (> 10 times ULN), Myoglobin blood and myoglobin, can be impaired.

    There have been very rare reports that have muscle necrosis through the immunity (IMNM) during or after treatment with some statins. IMNM is clinically characterized by prolonged thigh muscle weakness and increased serum creatin concentration, not all when stopping treatment with statin.

    Interstitial lung disease

    There has been an interstitial lung disease report when using some statins in some cases, especially when treated for prolonged treatment. The expression may include breathing, dry cough and general health reduction (fatigue, weight loss and fever). Stop taking the drug if there is a suspected patient with interstitial pneumonia.

    Endocrine function

    There have been reports on increasing the level of hemoglobin A1C and blood sugar when hungry when using the drug. However, the risk of hyperglycemia is lowered by a decrease in blood vessel risk to the statin group.

    The ability to drive and operate machinery

    unknown.

    Pregnancy

    contraindicated to use Atorvastatin during pregnancy.

    Breastfeeding period

    Effects of simultaneous medications with Atorvastatin

    Atorvastatin is metabolized by Cytocrom P450 3A4 (CYP3A4) and is a substrate of transport protein such as OatP1B1 transport protein. Concomitance with CYP3A4 inhibitors or transportation proteins can increase plasma Atorvastatin levels and increase the risk of muscle disease. The risk can also increase when using atorvastatin simultaneously with other drugs can also cause muscle disease such as fibric acid derivatives and ezetimib.

    CYP3A4 inhibitors

    Strong CYP3A4 inhibitors (such as Ciclosporin, Telithromycin, Clarithromycin, Delavirdin, Stiripentol, Ketoconazol, Voriconazole, Itraconazol, Posaconazole and HIV Ritonavir, Lopinavir, Atazanavir, Indir, Indires, Indires, Indires Darunavir ...) can significantly increase Atorvastatin levels.

    Average CYP3A4 inhibitors (such as erythromycin, diltiazem, verapamil and fluconazole) may increase plasma Atorvastatin levels.

    CYP3A4 induction drugs

    Used at the Atorvastatin period with CYP3A4 induction drugs (such as Efavirenz, Rifampin, St. John) can reduce plasma Atorvastatin levels.

    Transport protein inhibitors (such as ciclosporin) may increase Atorvastatin levels.

    gemfibrozil/Fibric acid derivatives

    Only use fibrats sometimes related to mechanical events, including muscle pattern. The risk of these variables may increase when used simultaneously fibric acid derivatives with Atorvastatin. If it is necessary to use atorvastatin combination with fibric acid derivatives, the lowest dose of Atorvastatin should be effective and appropriate patient monitoring.

    ezetimibe

    Only use Ezetimibe sometimes related to mechanical events, including muscle pattern. This risk may increase when using Ezetimibe simultaneously with Atorvastatin.

    Colestipol

    Atorvastatin concentration and metabolites have active activity in plasma (radioactive Atorvastatin concentration: 0.74) when simultaneously used Colestipol with Atorvastatin. However, the effect on lipid when using Atorvastatin with Colestipol is higher than when taking only one of the two drugs.

    Fusidic acid

    The risk of muscle disease, including muscle pilot increases when using fusidic acid system with systemic sugar with statins.

    colchicin

    Be cautious when using due to a report on muscle disease.

    influence Atorvastatin on other drugs used simultaneously

    digoxin

    When using simultaneously, the dose repeats digoxin and 10mg of atorvastatin, the concentration of Digoxin stability increases slightly.

    Oral contraceptives

    Simultaneous use of Atorvastatin with oral contraceptives can increase the concentration of Norethindron and Ethinyl Oestradiol.

    warfarin

    should determine prothrombin time before starting Atorvastatin in patients who are taking Coumarin antifiers and regularly during the first time of treatment to ensure no significant change in prothrombin time occurs. Atorvastatin is not related to bleeding or changing the time of prothrombin in patients who do not take antifinal drugs.

    Children

    Medicinal interaction - The drug has only been realized on adults. Drug interaction in children is unknown. Drug interactions and related warnings atorvastatin in adults should be considered for children.

    Storage

    Store under 30 ° C.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords